ARCHIVES

Drasga and Einhorn Respond to Single Payer Proposal Rebuttal

This article is from The Cancer Letter archive.

Vol. 40 No. 07 | February 14, 2014

Download PDF Visit The Full Archive

Related Articles

Phase II Study Cohort Fails To Overcome Erlotinib Resistance

April 26, 2013

COG’s Peter Adamson Has A Conversation With The Cancer Letter

March 15, 2013

IVAX And It’s Portfolio

December 22, 1994

Greenberg: More Work Needs to be Done

November 7, 2014

CTEP Drafts FDA Approval Guidelines

March 4, 1988

Ethics Commission To Take Up Again Compensation Issue

September 11, 1981